Most Of First 50 Million Oxford Shots For India: Serum Institute Head | Read

PUBLISHED ON: December 28, 2020 | Duration: 2 min, 33 sec

facebooktwitteremailkoo
loading..
Stating that the delay in approval for Oxford-AstraZeneca COVID-19 vaccine - being mass produced by his company - was not worrying, Serum Institute of India's (SII) Adar Poonawalla said the inoculant is likely to get a go-ahead in the United Kingdom "by end of this December or by early January".
ALSO WATCH
WHO Says 'The End Is In Sight' For Covid Pandemic 

................................ Advertisement ................................

Short videosBy Firework

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com